Contribution of fasting hyperinsulinemia to prediction of atherosclerotic cardiovascular disease status in 293 hyperlipidemic patients (Q51559659)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Contribution of fasting hyperinsulinemia to prediction of atherosclerotic cardiovascular disease status in 293 hyperlipidemic patients	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10582554

Contribution of fasting hyperinsulinemia to prediction of atherosclerotic cardiovascular disease status in 293 hyperlipidemic patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10582554

atherosclerosis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

cardiovascular disease

1 reference

based on heuristic

inferred from title

author name string

Glueck CJ

1

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10582554

Lang JE

2

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10582554

Tracy T

3

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10582554

Sieve-Smith L

4

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10582554

Wang P

5

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10582554

publication date

1 November 1999

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10582554

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10582554

48

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10582554

11

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10582554

1437-1444

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10582554

Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990156-7

7 January 2021

Hyperinsulinemia and cardiovascular disease in elderly men: the Honolulu Heart Program

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990156-7

7 January 2021

Factors of the insulin resistance syndrome in nondiabetic and diabetic elderly Japanese-American men.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990156-7

7 January 2021

Hyperinsulinemia as an independent risk factor for ischemic heart disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990156-7

7 January 2021

Relationships of abdominal obesity and hyperinsulinemia to angiographically assessed coronary artery disease in men with known mutations in the LDL receptor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990156-7

7 January 2021

Insulin resistance as an independent risk factor for carotid wall thickening

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990156-7

7 January 2021

Central obesity, insulin resistance, syndrome X, lipoprotein(a), and cardiovascular risk in Indians, Malays, and Chinese in Singapore

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990156-7

7 January 2021

Individuals with high total cholesterol/HDL cholesterol ratios are insulin resistant

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990156-7

7 January 2021

Heritability of factors of the insulin resistance syndrome in women twins

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990156-7

7 January 2021

Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990156-7

7 January 2021

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990156-7

7 January 2021

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990156-7

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990156-7

7 January 2021

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990156-7

7 January 2021

Evidence that homocysteine is an independent risk factor for atherosclerosis in hyperlipidemic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990156-7

7 January 2021

Relationships between lipoprotein(a), lipids, apolipoproteins, basal and stimulated fibrinolytic regulators, and D-dimer

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990156-7

7 January 2021

Anticardiolipin antibodies in clinical conditions associated with a risk of thrombotic events

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990156-7

7 January 2021

Metformin therapy is associated with a decrease in plasma plasminogen activator inhibitor-1, lipoprotein(a), and immunoreactive insulin levels in patients with the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990156-7

7 January 2021

Leptin is involved in gender-related differences in insulin sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990156-7

7 January 2021

Gender differences in insulin-stimulated glucose utilization among African-Americans.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990156-7

7 January 2021

Computed axial tomographic scan measurement of abdominal fat distribution and its correlation with anthropometry and insulin secretion in healthy Asian Indians

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990156-7

7 January 2021

The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990156-7

7 January 2021

Epidemiologic aspects of lipid abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990156-7

7 January 2021

The new pathophysiology of coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990156-7

7 January 2021

Lipoprotein(a) interactions with lipid and non-lipid risk factors in patients with early onset coronary artery disease: results from the NHLBI Family Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990156-7

7 January 2021

Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990156-7

7 January 2021

Progression of coronary artery disease in young male post-infarction patients is linked to disturbances of carbohydrate and lipoprotein metabolism and to impaired fibrinolytic function

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990156-7

7 January 2021

Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990156-7

7 January 2021

Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990156-7

7 January 2021

How good a marker is insulin level for insulin resistance?

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990156-7

7 January 2021

Estimates of in vivo insulin action in man: comparison of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990156-7

7 January 2021

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990156-7

7 January 2021

The natural history of impaired glucose tolerance in the Pima Indians

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990156-7

7 January 2021

Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990156-7

7 January 2021

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990156-7

7 January 2021

Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990156-7

7 January 2021

Anti-cardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990156-7

7 January 2021

Antibodies against cardiolipin and oxidatively modified LDL in 50-year-old men predict myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990156-7

7 January 2021

Evidence that anticardiolipin antibodies are independent risk factors for atherosclerotic vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990156-7

7 January 2021

Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990156-7

7 January 2021

Metabolic abnormalities in hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990156-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0026-0495(99)90156-7

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10582554

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10582554

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51559659&oldid=2277162309"